0 XP   0   0   0

America Great Health
Buy, Hold or Sell?

Should you buy, hold or sell America Great Health?

I guess you are interested in America Great Health. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse America Great Health

Let's start. I'm going to help you getting a better view of America Great Health. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is America Great Health even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how America Great Health is doing in the market. If the company is worth buying. The latest step is to find out how other investors value America Great Health. The closing price on 2023-03-24 was $0.0072 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
America Great Health Daily Candlestick Chart
America Great Health Daily Candlestick Chart
Summary









1. Valuation of America Great Health




Current price per share

$0.01

2. Growth of America Great Health




Is America Great Health growing?

Current yearPrevious yearGrowGrow %
How rich?-$4m-$944.2k-$2.7m-74.6%

How much money is America Great Health making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$542.5k-$732.2k?
Net Profit Margin-5,189.1%-444.4%--

How much money comes from the company's main activities?

3. Financial Health of America Great Health




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#1137 / 1230

Most Revenue
#733 / 1230

Most Profit
#309 / 1230

Most Efficient
#1094 / 1230


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of America Great Health.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit America Great Health earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • A Net Profit Margin of -351.1% means that $-3.51 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of America Great Health:

  • The MRQ is -351.1%. The company is making a huge loss. -2
  • The TTM is -5,189.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-351.1%TTM-5,189.1%+4,838.0%
TTM-5,189.1%YOY-444.4%-4,744.7%
TTM-5,189.1%5Y-1,684.4%-3,504.7%
5Y-1,684.4%10Y-952.8%-731.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-351.1%-219.6%-131.5%
TTM-5,189.1%-341.4%-4,847.7%
YOY-444.4%-311.9%-132.5%
5Y-1,684.4%-558.0%-1,126.4%
10Y-952.8%-674.4%-278.4%
1.1.2. Return on Assets

Shows how efficient America Great Health is using its assets to generate profit.

  • Above 5% is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • -51.5% Return on Assets means that America Great Health generated $-0.51 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of America Great Health:

  • The MRQ is -51.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -365.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.5%TTM-365.8%+314.4%
TTM-365.8%YOY-2,515.7%+2,149.9%
TTM-365.8%5Y-1,051.2%+685.3%
5Y-1,051.2%10Y-862.0%-189.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.5%-12.6%-38.9%
TTM-365.8%-12.2%-353.6%
YOY-2,515.7%-11.4%-2,504.3%
5Y-1,051.2%-15.2%-1,036.0%
10Y-862.0%-17.5%-844.5%
1.1.3. Return on Equity

Shows how efficient America Great Health is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • 0.0% Return on Equity means America Great Health generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of America Great Health:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,216.1%+1,216.1%
5Y-1,216.1%10Y-746.7%-469.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.4%+15.4%
TTM--16.1%+16.1%
YOY--13.3%+13.3%
5Y-1,216.1%-19.8%-1,196.3%
10Y-746.7%-20.7%-726.0%

1.2. Operating Efficiency of America Great Health.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient America Great Health is operating .

  • Measures how much profit America Great Health makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • An Operating Margin of -246.9% means the company generated $-2.47  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of America Great Health:

  • The MRQ is -246.9%. The company is operating very inefficient. -2
  • The TTM is -4,687.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-246.9%TTM-4,687.3%+4,440.4%
TTM-4,687.3%YOY-61,548.0%+56,860.7%
TTM-4,687.3%5Y-13,566.3%+8,879.0%
5Y-13,566.3%10Y-7,140.2%-6,426.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-246.9%-228.3%-18.6%
TTM-4,687.3%-321.4%-4,365.9%
YOY-61,548.0%-350.6%-61,197.4%
5Y-13,566.3%-540.9%-13,025.4%
10Y-7,140.2%-660.9%-6,479.3%
1.2.2. Operating Ratio

Measures how efficient America Great Health is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.47 means that the operating costs are $3.47 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of America Great Health:

  • The MRQ is 3.469. The company is inefficient in keeping operating costs low. -1
  • The TTM is 55.564. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.469TTM55.564-52.096
TTM55.564YOY4.988+50.576
TTM55.5645Y17.110+38.455
5Y17.11010Y9.856+7.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4693.426+0.043
TTM55.5644.100+51.464
YOY4.9884.671+0.317
5Y17.1107.250+9.860
10Y9.8568.489+1.367

1.3. Liquidity of America Great Health.

1.3. Liquidity
1.3.1. Current Ratio

Measures if America Great Health is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.08 means the company has $0.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of America Great Health:

  • The MRQ is 0.077. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.091. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.077TTM0.091-0.015
TTM0.091YOY0.266-0.175
TTM0.0915Y0.074+0.018
5Y0.07410Y0.409-0.336
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0774.890-4.813
TTM0.0915.355-5.264
YOY0.2666.134-5.868
5Y0.0746.368-6.294
10Y0.4096.495-6.086
1.3.2. Quick Ratio

Measures if America Great Health is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • A Quick Ratio of 0.03 means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of America Great Health:

  • The MRQ is 0.027. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.032. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.032-0.005
TTM0.032YOY0.081-0.048
TTM0.0325Y0.028+0.004
5Y0.02810Y0.157-0.129
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0274.342-4.315
TTM0.0324.966-4.934
YOY0.0815.571-5.490
5Y0.0285.930-5.902
10Y0.1575.918-5.761

1.4. Solvency of America Great Health.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of America Great Health assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare America Great Health to Biotechnology industry mean.
  • A Debt to Asset Ratio of 12.39 means that America Great Health assets are financed with 1,238.6% credit (debt) and the remaining percentage (100% - 1,238.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of America Great Health:

  • The MRQ is 12.386. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 11.249. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ12.386TTM11.249+1.137
TTM11.249YOY925.905-914.657
TTM11.2495Y345.848-334.599
5Y345.84810Y191.516+154.332
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3860.290+12.096
TTM11.2490.282+10.967
YOY925.9050.278+925.627
5Y345.8480.373+345.475
10Y191.5160.411+191.105
1.4.2. Debt to Equity Ratio

Measures if America Great Health is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare America Great Health to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of America Great Health:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y100.791-100.791
5Y100.79110Y54.544+46.247
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.333-0.333
TTM-0.341-0.341
YOY-0.274-0.274
5Y100.7910.418+100.373
10Y54.5440.453+54.091

2. Market Valuation of America Great Health

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings America Great Health generates.

  • Above 15 is considered overpriced but always compare America Great Health to the Biotechnology industry mean.
  • A PE ratio of -855.93 means the investor is paying $-855.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of America Great Health:

  • The EOD is -832.801. Company is losing money. -2
  • The MRQ is -855.934. Company is losing money. -2
  • The TTM is -993.327. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-832.801MRQ-855.934+23.133
MRQ-855.934TTM-993.327+137.393
TTM-993.327YOY-279,165.688+278,172.361
TTM-993.3275Y-80,281.465+79,288.138
5Y-80,281.46510Y-41,909.382-38,372.083
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-832.801-5.986-826.815
MRQ-855.934-7.721-848.213
TTM-993.327-10.277-983.050
YOY-279,165.688-21.989-279,143.699
5Y-80,281.465-17.927-80,263.538
10Y-41,909.382-18.153-41,891.229
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of America Great Health.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of America Great Health:

  • The MRQ is -446.618. Very Bad. -2
  • The TTM is -552.503. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-446.618TTM-552.503+105.884
TTM-552.503YOY-170,136.136+169,583.633
TTM-552.5035Y-37,561.898+37,009.395
5Y-37,561.89810Y-17,891.770-19,670.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-446.618-5.636-440.982
TTM-552.503-7.915-544.588
YOY-170,136.136-15.813-170,120.323
5Y-37,561.898-13.782-37,548.116
10Y-17,891.770-13.070-17,878.700

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of America Great Health is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -38.70 means the investor is paying $-38.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of America Great Health:

  • The EOD is -37.654. Bad. Book ratio is negative. -2
  • The MRQ is -38.700. Bad. Book ratio is negative. -2
  • The TTM is -181.804. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-37.654MRQ-38.700+1.046
MRQ-38.700TTM-181.804+143.104
TTM-181.804YOY-9,503.052+9,321.249
TTM-181.8045Y-3,544.131+3,362.327
5Y-3,544.13110Y-2,692.256-851.875
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-37.6541.733-39.387
MRQ-38.7002.046-40.746
TTM-181.8042.608-184.412
YOY-9,503.0524.052-9,507.104
5Y-3,544.1313.689-3,547.820
10Y-2,692.2563.871-2,696.127
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of America Great Health compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.000+109%0.000+253%0.000+15%0.000-41%
Book Value Growth--0.9550.879+9%-0.323+134%0.653+46%0.601+59%
Book Value Per Share--0.0000.000-8%0.000-77%0.000-75%0.000-81%
Book Value Per Share Growth--0.9550.879+9%-0.323+134%0.653+46%0.601+59%
Current Ratio--0.0770.091-16%0.266-71%0.074+4%0.409-81%
Debt To Asset Ratio--12.38611.249+10%925.905-99%345.848-96%191.516-94%
Debt To Equity Ratio----0%-0%100.791-100%54.544-100%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.000+599%0.000+2032%0.000+471%0.000+230%
Eps Growth--1.9160.766+150%-1223.189+63925%-244.714+12869%-133.557+7069%
Free Cash Flow Per Share--0.0000.000+105%0.000+14%0.000-33%0.000-47%
Free Cash Flow Per Share Growth--1.1100.343+224%-5.588+603%-2.590+333%-1.804+263%
Free Cash Flow To Equity Per Share--0.0000.000+471%0.000+500%0.000+244%0.000+145%
Free Cash Flow To Equity Per Share Growth--2.2700.745+205%-742.080+32784%-146.682+6560%-94.435+4259%
Gross Profit Margin--1.0261.020+1%1.004+2%1.005+2%0.950+8%
Intrinsic Value_10Y_max--0.000--------
Intrinsic Value_10Y_min---0.001--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min--0.000--------
Net Profit Margin---3.511-51.891+1378%-4.444+27%-16.844+380%-9.528+171%
Operating Margin---2.469-46.873+1799%-615.480+24832%-135.663+5396%-71.402+2792%
Operating Ratio--3.46955.564-94%4.988-30%17.110-80%9.856-65%
Pb Ratio-37.654+3%-38.700-181.804+370%-9503.052+24456%-3544.131+9058%-2692.256+6857%
Pe Ratio-832.801+3%-855.934-993.327+16%-279165.688+32515%-80281.465+9279%-41909.382+4796%
Peg Ratio---446.618-552.503+24%-170136.136+37994%-37561.898+8310%-17891.770+3906%
Price Per Share0.007-3%0.0070.028-74%0.132-94%0.041-82%0.027-73%
Price To Total Gains Ratio-881.470+3%-905.955-14716323.041+1624299%-85454.316+9333%-4234741.894+467334%-1915042.742+211284%
Profit Growth--1.9160.766+150%-3.983+308%-0.666+135%-0.032+102%
Quick Ratio--0.0270.032-17%0.081-66%0.028-4%0.157-83%
Return On Assets---0.515-3.658+611%-25.157+4787%-10.512+1942%-8.620+1574%
Return On Equity----0%-0%-12.1610%-7.4670%
Revenue Growth--0.510-3.794+844%0.014+3541%-1.680+430%0.400+27%
Total Gains Per Share--0.0000.000+109%0.000+253%0.000+15%0.000-41%
Total Gains Per Share Growth---50606.777-12650.638-75%-3.072-100%-3614.666-93%-1573.894-97%
Usd Book Value---4032753.000-3713996.500-8%-944230.250-77%-1007137.500-75%-752352.816-81%
Usd Book Value Change Per Share--0.0000.000+109%0.000+253%0.000+15%0.000-41%
Usd Book Value Per Share--0.0000.000-8%0.000-77%0.000-75%0.000-81%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.000+599%0.000+2032%0.000+471%0.000+230%
Usd Free Cash Flow---143244.000-293054.000+105%-163480.000+14%-93716.150-35%-65517.053-54%
Usd Free Cash Flow Per Share--0.0000.000+105%0.000+14%0.000-33%0.000-47%
Usd Free Cash Flow To Equity Per Share--0.0000.000+471%0.000+500%0.000+244%0.000+145%
Usd Price Per Share0.007-3%0.0070.028-74%0.132-94%0.041-82%0.027-73%
Usd Profit---182336.000-1274808.500+599%-542585.750+198%-372309.100+104%-252942.079+39%
Usd Revenue--51938.00025702.500+102%89172.250-42%23277.300+123%83754.500-38%
Usd Total Gains Per Share--0.0000.000+109%0.000+253%0.000+15%0.000-41%
 EOD+2 -3MRQTTM+27 -11YOY+27 -115Y+27 -1210Y+21 -18

3.2. Fundamental Score

Let's check the fundamental score of America Great Health based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-832.801
Price to Book Ratio (EOD)Between0-1-37.654
Net Profit Margin (MRQ)Greater than0-3.511
Operating Margin (MRQ)Greater than0-2.469
Quick Ratio (MRQ)Greater than10.027
Current Ratio (MRQ)Greater than10.077
Debt to Asset Ratio (MRQ)Less than112.386
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.515
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of America Great Health based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.076
Ma 20Greater thanMa 500.009
Ma 50Greater thanMa 1000.009
Ma 100Greater thanMa 2000.008
OpenGreater thanClose0.008
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets354
Total Liabilities4,387
Total Stockholder Equity-3,964
 As reported
Total Liabilities 4,387
Total Stockholder Equity+ -3,964
Total Assets = 354

Assets

Total Assets354
Total Current Assets214
Long-term Assets214
Total Current Assets
Cash And Cash Equivalents 75
Net Receivables 1
Inventory 122
Other Current Assets 17
Total Current Assets  (as reported)214
Total Current Assets  (calculated)214
+/-0
Long-term Assets
Property Plant Equipment 98
Long-term Assets Other 42
Long-term Assets  (as reported)140
Long-term Assets  (calculated)140
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,781
Long-term Liabilities1,606
Total Stockholder Equity-3,964
Total Current Liabilities
Short-term Debt 220
Accounts payable 1,434
Other Current Liabilities 957
Total Current Liabilities  (as reported)2,781
Total Current Liabilities  (calculated)2,611
+/- 170
Long-term Liabilities
Long term Debt Total 1,132
Long-term Liabilities Other 473
Long-term Liabilities  (as reported)1,606
Long-term Liabilities  (calculated)1,606
+/-0
Total Stockholder Equity
Retained Earnings -8,604
Accumulated Other Comprehensive Income 0
Capital Surplus 4,640
Total Stockholder Equity (as reported)-3,964
Total Stockholder Equity (calculated)-3,964
+/-0
Other
Cash and Short Term Investments 75
Common Stock Shares Outstanding 21,090,218
Current Deferred Revenue170
Liabilities and Stockholders Equity 354
Net Debt 1,287
Net Tangible Assets -3,964
Minority Interest -69
Short Long Term Debt Total 1,362



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-03-312012-12-312012-09-302012-03-312011-12-312011-09-302011-06-302011-03-31
> Total Assets 
0
7
0
0
0
1
5
56
20
0
0
0
0
40
63
24
24
412
551
412
200
254
0
4
4
1
1
13
13
0
0
0
0
0
0
4
12
0
0
4
491
604
467
336
336
354
35433633646760449140012400000013131144025420041255141224246340000020565100070
   > Total Current Assets 
0
7
0
0
0
0
5
56
20
0
0
0
0
40
63
0
24
0
551
412
200
254
0
4
4
1
1
0
0
0
0
0
0
0
0
4
0
0
0
4
351
472
346
197
197
214
21419719734647235140004000000001144025420041255102406340000020565000070
       Cash And Cash Equivalents 
0
7
0
0
0
0
5
56
20
0
0
0
0
40
22
24
24
36
442
36
15
8
5
4
4
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
152
206
106
63
63
75
756363106206152000000000000011445815364423624242240000020565000070
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
12
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
9
9
3
50
76
81
1
1
1
11181765039933000000000000012200000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
0
0
229
0
229
243
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
141
118
10
17
17
17
1717171011814118000000000000000002352432290229004100000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
0
0
0
0
0
12
151
139
151
140
131
121
140
140
140
140140140121131140151139151120000000130000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
151
139
151
140
131
119
118
118
98
981181181191311401511391510000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000013000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
22
0
0
00223000000000000000000000000000000000000000000
> Total Liabilities 
0
10
0
0
10
60
180
219
247
50
202
353
512
711
869
1,016
1,017
1,162
1,212
1,163
1,225
769
17
52
52
78
87
121
121
0
0
0
0
0
183
219
127
159
171
219
1,287
3,199
3,569
4,197
4,197
4,387
4,3874,1974,1973,5693,1991,2872191711591272191830000012112187785252177691,2251,1631,2121,1621,0171,01686971151235320250247219180601000100
   > Total Current Liabilities 
0
10
0
0
10
60
40
54
107
1
5
39
140
281
381
481
481
70
142
70
90
769
17
52
52
78
87
121
121
152
159
168
171
181
183
219
127
159
171
219
432
2,029
2,362
2,757
2,757
2,781
2,7812,7572,7572,3622,029432219171159127219183181171168159152121121877852521776990701427048148138128114039511075440601000100
       Short-term Debt 
0
0
0
0
5
0
10
10
35
0
0
0
0
0
0
0
10
0
10
10
10
606
17
44
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
49
0
52
213
0
255
220
22025502135204900000000000011144176061010100100000000351010050000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
44
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
184
153
0
015318416000000000000000011144170000000000000000000000
       Accounts payable 
0
10
0
0
5
50
28
44
72
0
0
30
130
0
0
0
6
5
6
5
5
7
17
52
15
11
15
20
20
26
31
39
38
36
35
49
26
31
38
49
39
1,752
1,581
1,438
1,434
1,434
1,4341,4341,4381,5811,75239493831264935363839312620201511155217755656000130300072442850500100
       Other Current Liabilities 
0
0
0
0
0
10
2
0
0
1
5
9
9
281
381
471
471
55
126
55
75
156
17
52
52
67
72
1
101
1
1
1
2
2
2
2
101
127
131
168
341
225
524
491
2,345
957
9572,34549152422534116813112710122221111011726752521715675551265547147138128199510021000000
   > Long-term Liabilities 
0
0
0
0
0
0
140
165
140
49
197
315
372
430
488
0
535
0
1,070
1,093
1,135
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
102
89
102
856
1,169
1,207
1,439
1,439
1,606
1,6061,4391,4391,2071,1698561028910200000000000000001,1351,0931,0700535048843037231519749140165140000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,120
1,032
0
0
1,132
1,132001,0321,12000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
49
197
314
372
431
488
535
563
590
618
636
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138
384
0
0
00384138000000000000000000000063661859056353548843137231419749000000000
> Total Stockholder Equity
0
-3
0
0
-10
-59
-175
-163
-227
-50
-202
-353
-512
-672
-830
0
-998
0
-662
-748
-1,021
-515
0
-48
-48
-77
-86
-107
-107
0
0
0
0
0
-182
-215
-115
-159
-171
-215
-796
-2,595
-3,102
-3,802
-3,802
-3,964
-3,964-3,802-3,802-3,102-2,595-796-215-171-159-115-215-18200000-107-107-86-77-48-480-515-1,021-748-6620-9980-830-672-512-353-202-50-227-163-175-59-1000-30
   Common Stock
0
0
0
0
0
0
49
49
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000494949000000
   Retained Earnings Total Equity-8,60400-6,298-5,6880-16,743-3,253-3,2350000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,067
3,070
16,446
0
3,093
3,195
0
0
4,640
4,640003,1953,093016,4463,0703,0670000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
21
0
0
21
21
-113
-86
-87
0
0
0
0
0
0
0
0
0
525
550
550
1,186
3,062
0
3,062
3,062
3,062
0
3,062
0
0
0
0
0
0
0
3,062
3,062
3,068
3,072
0
3,093
3,195
0
4,620
4,640
4,6404,62003,1953,09303,0723,0683,0623,06200000003,06203,0623,0623,06203,0621,186550550525000000000-87-86-113212100210



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue196
Cost of Revenue-144
Gross Profit5151
 
Operating Income (+$)
Gross Profit51
Operating Expense-295
Operating Income-244-244
 
Operating Expense (+$)
Research Development-
Selling General Administrative295
Selling And Marketing Expenses86
Operating Expense295381
 
Net Interest Income (+$)
Interest Income0
Interest Expense-20
Net Interest Income-191-20
 
Pretax Income (+$)
Operating Income-244
Net Interest Income-191
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-269-218
EBIT - interestExpense = -4,754
-269
-249
Interest Expense20
Earnings Before Interest and Taxes (ebit)-4,734-249
Earnings Before Interest and Taxes (ebitda)-249
 
After tax Income (+$)
Income Before Tax-269
Tax Provision--
Net Income From Continuing Ops-4,925-269
Net Income-269
Net Income Applicable To Common Shares-4,866
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses439
Total Other Income/Expenses Net-25191
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
AHZ0.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of AHZ0.F.

AHZ0.F Daily Candlestick Chart
9VU.F
19 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 9VU.F.

9VU.F Daily Candlestick Chart
9TD.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 9TD.F.

9TD.F Daily Candlestick Chart
9PZ.F
19 hours ago

I found you a Golden Cross on the daily chart of 9PZ.F.

9PZ.F Daily Candlestick Chart
98B.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 98B.F.

98B.F Daily Candlestick Chart
8ZU.F
19 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 8ZU.F.

8ZU.F Daily Candlestick Chart
8QQ.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 8QQ.F.

8QQ.F Daily Candlestick Chart
8K6.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 8K6.F.

8K6.F Daily Candlestick Chart
8J4.F
19 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 8J4.F.

8J4.F Daily Candlestick Chart
8HQ.F
19 hours ago

I found you a RSI Bullish Reversal Divergence on the daily chart of 8HQ.F.

8HQ.F Daily Candlestick Chart
7ZG.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 7ZG.F.

7ZG.F Daily Candlestick Chart
7O41.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 7O41.F.

7O41.F Daily Candlestick Chart
7N20.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 7N20.F.

7N20.F Daily Candlestick Chart
7IA.F
19 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of 7IA.F.

7IA.F Daily Candlestick Chart
7F4.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 7F4.F.

7F4.F Daily Candlestick Chart
77Q.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 77Q.F.

77Q.F Daily Candlestick Chart
74G.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 74G.F.

74G.F Daily Candlestick Chart
6YG.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6YG.F.

6YG.F Daily Candlestick Chart
6WZ.F
19 hours ago

I found you a RSI Bearish Hidden Divergence on the daily chart of 6WZ.F.

6WZ.F Daily Candlestick Chart
6VY.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6VY.F.

6VY.F Daily Candlestick Chart
6UY.F
19 hours ago

I found you a Death Cross on the daily chart of 6UY.F.

6UY.F Daily Candlestick Chart
6R4.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 6R4.F.

6R4.F Daily Candlestick Chart
6NCA.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 6NCA.F.

6NCA.F Daily Candlestick Chart
65R.F
19 hours ago

I found you a Death Cross on the daily chart of 65R.F.

65R.F Daily Candlestick Chart